ABSTRACT Delta-like homologue 1 (Dlk1), an atypical Notch ligand, is known to have roles in growth and development, stem cell maintenance, and cancer. Evidence suggests that Dlk1 expression patterns are more complex than previously appreciated, with multiple isoforms expressed in various tissues in both the embryo and adult. However, the early embryonic expression of Dlk1 has not been well examined. Given that tissue specific Dlk1 knockouts have to date failed to recapitulate phenotypes associated with the conventional Dlk1 loss of function model, a better understanding of early Dlk1 expression is important. To address this question, we have examined Dlk1 expression during the early stages of mouse embryogenesis. Dlk1 expression was first detected at Theiler Stage 14 (TS14), and its expression pattern persisted in specific tissues through TS20. Further, we found that all known Dlk1 splice isoforms were expressed in early embryogenesis, with Dlk1-A and Dlk1-C/C2 isoforms being expressed at the highest levels. The broad co-expression of multiple Dlk1 isoforms corroborates recent work suggesting that Dlk1-mediated signaling may act through multiple DLK1 isoforms to balance differentiation.
differentiation in a variety of cell types. This may further suggest that the embryonic functions of Dlk1 require the regulated expression of multiple DLK1 isoforms, highlighting the importance of alternative mRNA splicing in Dlk1-mediated signaling.
Dlk1 mRNA distribution has not been studied in early embryogenesis. In late embryogenesis, Dlk1 RNA expression has been reported in the liver, lung, muscle, vertebrae, pancreas, pituitary, and adrenal glands at embryonic day 12.5 (E12.5), and expression is found to be dramatically down-regulated at E16.5 (Yevtodiyenko and Schmidt, 2006) . Dlk1 null mice exhibit exhibit growth retardation, skeletal deformations, eyelid abnormalities, and postnatal hypertrophic adipocytes (Moon et al., 2002) . In contrast, overexpression of Dlk1 via transgene leads to an enhanced growth phenotype, defects in cartilage and bone, and perinatal lethality (Da Rocha et al., 2009) . Together, these studies indicate roles for Dlk1 in growth and development, with potential functions in tissues known to express Dlk1 at E12.5. However, a recent study made conditional deletions of Dlk1 in several tissues including pituitary somatotrophs, pancreatic beta cells and endothelial cells. None of these tissue specific deletions recapitulate the phenotypes of Dlk1 null animals, suggesting that the requirements for Dlk1 during embryogenesis are complex, and that understanding the Dlk1 expression pattern during early embryogenesis may give further hints about its functions (Appelbe et al., 2013) .
Given these facts, and the finding that DLK1 protein expression can be observed as early as E10 (Falix et al., 2013) , we performed a study of Dlk1 expression during early mouse embryogenesis. Here, we demonstrate that Dlk1 expression is detectable as early as Theiler Stage 13 (TS13, E8.5 on our background). Thus, Dlk1 is expressed during the developmental periods in which terminal differentiation and organogenesis begin to occur in the mouse embryo. Expression patterns at these early stages are tissue specific, with Dlk1 expression highest in regions where regulation of cell differentiation is important. Interestingly, we find that all known Dlk1 isoforms are expressed during these early stages of embryogenesis, and we find that transcripts encoding the full-length and membrane-bound forms are co-expressed on the whole-tissue level. These results corroborate and extend previous Dlk1 expression studies. Further, this suggests that the tissues utilizing Dlk1-mediated signaling do so through more than one isoform, possibly to mediate signaling between the stroma and parenchyma within a tissue in a paracrine fashion as has been previously suggested (Andersen et al., 2013; Appelbe et al., 2013) .
Results

All known Dlk1 isoforms are expressed during early mouse embryogenesis
To determine which Dlk1 isoforms are expressed during early embryogenesis, we examined mouse embryos at TS13 (~E8.5) and TS18 (~E10.5; Fig. 1 ). Using primers that flank the alternativelyspliced region of Dlk1 exon 5 (Fig. 1A) , we simultaneously amplified all Dlk1 transcripts (Fig. 1B) . PCR products were subcloned, and sequenced, and we find that all six previously identified Dlk1 isoforms (A, B, C, C2, D, and D2) are expressed in mouse embryos (Smas et al., 1994; Fig. 1A ). An additional PCR product was subsequently determined to be a heteroduplex (Fig. 1B) . The highest levels of expression detected at these stages were represented by the Dlk1-A and Dlk1-C/C2 transcripts, which give rise to secreted and membrane-bound forms of DLK1, respectively (Smas et al., 1997; Yevtodiyenko and Schmidt, 2006; Fig. 1B) . These data indicate that all previously described Dlk1 isoforms are expressed during early mouse embryogenesis, and that it is the Dlk1-A and Dlk1-C/ C2 isoforms that predominate at these stages of development.
Dlk1 is expressed in a tissue-specific manner during embryogenesis
Having detected expression of Dlk1 during early embryogenesis, we examined the spatial distribution of Dlk1 transcripts during this period of development. In situ hybridization was performed to simultaneously examine the expression pattern of all Dlk1 isoforms using a probe spanning EGF repeats 4-6, which are shared among all known isoforms (pan-Dlk1 expression; Fig. 2 ). No expression was observed at TS12 (~E8.0; Fig. 2A ). Robust Dlk1 expression is first detected at TS14, in the first branchial arch (BA) and the olfactory epithelium (OE; Fig. 2B ). At TS18, expression is also apparent in the liver, limb buds, otic vesicle, and mature somites ( Figure 2C ). At this stage, expression is strong in both the first and second branchial arch structures, as well as the OE. At TS20, expression has been refined in the OE and the BA and is maintained in the liver and somites (Fig. 2D) . The expression patterns observed at these early developmental stages are consistent with the previously reported functions of Dlk1, though embryonic expression in the branchial arches and olfactory epithelium has not been previously reported.
Dlk1 expression in the branchial arches and olfactory epithelium is robust and specific
As the first specific site of pan-Dlk1 expression is in the BA and OE at TS14, we examined these structures in more detail throughout early embryogenesis (Fig. 3) . Pan-Dlk1 expression is detected in the mandibular process of the first BA at TS14 (Fig.  3A) . As craniofacial development proceeds, Dlk1 expression is evident in the maxillary (MX) and mandibular processes (MD) as well as in the second branchial arch (Fig. 3B ). Dlk1 expression is refined as these tissues mature, becoming highly restricted in the MX, and more restricted in the MD and BA2 at TS18 (Fig. 3C) . By TS20, Dlk1 expression is downregulated in the craniofacial region, though it can still be observed in distinct puncta in the MX ( Fig. 3D; asterisks) . The olfactory placodes are specialized epithelial thickenings that invaginate to form the nasal pit. Pan-Dlk1 expression is evident in the olfactory epithelium (OE) of the placode at TS14 (Fig. 3A) . Expression in the OE intensifies at TS16 as it thickens (Fig. 3B) . Notably, as the placode invaginates at TS18, pan-Dlk1 expression becomes restricted to the marginal rim of the OE (Fig. 3C) . At TS20, pan-Dlk1 expression is again largely extinguished, though the detectable expression remains at the periphery of the OE (Fig. 3D) .
Dlk1 is expressed in the developing limb buds and presomitic mesoderm (PSM)
Given the previously suggested roles for Dlk1 in muscle development (Andersen et al., 2013) , we further examined the pan-Dlk1 expression pattern in the somites, limb buds and PSM. At TS16, Dlk1 expression is robust at the posterior and midline of (Fig. 4A) . At TS18, a condensation of Dlk1 expression is detected near the central limb bud (Fig. 4B) , and by TS20, pan-Dlk1 expression is detected as a stripe at the midline of the limb bud (Fig. 4C) . This observation corroborates studies that have found roles for Dlk1 in embryonic muscle development and muscle precursor cells (Andersen et al., 2013; Moon et al., 2002; Waddell et al., 2010) . Dlk1 has been proposed to function in modulation of the Notch signaling pathway. In the presomitic mesoderm (PSM) oscillatory Notch1 signaling in the PSM is critical for the regulation of the axial skeleton by the segmentation clock. We therefore examined the expression of Dlk1 in the PSM to determine whether its expression links it to the clock. Pan-Dlk1 expression in the PSM is only weakly detectable prior to TS16 (Fig. 4D) . Robust expression is observed at TS16, with a broad band of Dlk1 expression in the posterior PSM (Fig. 4E) , that is maintained at TS18 (Fig. 4F) . Unlike the expression of some other Notch pathway members, however, expression of Dlk1 in the PSM is stable, with no evidence of oscillatory expression (n=10). Thus it is unlikely that Dlk1 plays a significant role in the segmentation clock, despite the occasional observation of rib fusions and other axial skeleton abnormalities in Dlk1 mutant mice (Moon et al., 2002) .
respectively). Here, pan-Dlk1 expression has also intensified. (C) By TS18, pan-Dlk1 expression has become restricted to the periphery of the OE, with no detectable expression within the invaginating nasal pit. Expression has also become highly restricted in the MX, MB and BA2. (D) Expression in the OE has been reduced, but is still detectable at the periphery of the OE and in MX by TS20. In MB and BA2, expression has also been down-regulated.
Fig. 4. (Right) Dlk1 is expressed dynamically in the developing limb buds. Pan-Dlk1 in situ hybridization was examined in limb buds and the PSM at various embryonic stages. (A) Pan-Dlk1 is expressed in a restricted pattern near the center of the developing limb bud at TS16, with expression also detectable at the midline. (B) At TS18, the pan-Dlk1 expression pattern closely resembles that observed at TS16, though expression has intensified. (C) By TS20, the pan-Dlk1 expression pattern is elongated along the ventro-medial axis of the limb bud, and Dlk1 expression appears to have been downregulated in this tissue. (D-F) Pan-Dlk1 expression in the PSM is first detected after TS16, and appears as a broad stripe near the anterior boundary of the PSM. Expression here is not cyclic, and is detected throughout the developmental period during which somitogenesis occurs (data not shown).
Distinct Dlk1 isoforms are co-expressed in developing tissues during early embryogenesis
An in situ probe which will hybridize specifically with the Dlk1-A transcript, while not detecting Dlk1-B, -C or -D (see Fig. 1 ), was used to compare the specific expression pattern of Dlk1-A to the pan-Dlk1 expression patterns (Fig. 5) . At TS18, we find that the overall expression pattern of Dlk1-A is strikingly similar to that of pan-Dlk1 (Fig. 5) . All tissues observed to express Dlk1 were found to express Dlk1-A, although the intensity of staining varied somewhat from tissue to tissue. In the mature somites ( Fig. 5A and E) and FLB ( Fig. 5B and F) , Dlk1-A expression levels seem similar to those detected using the pan-Dlk1 probe. However, detection of Dlk1-A was weaker in the PSM (Fig. 5D and H) and during early limb bud development ( Fig. 5C and G) . However, given the nonquantitative nature of whole mount in situ analysis, it is difficult to ascertain whether these differences represent differential regulation of splicing in these tissues.
As an independent method to examine tissue specific splicing regulation, we examined Dlk1 expression by RT-PCR using RNA extracted from whole embryos, PSMs, hind limb buds, and fore limb bud tissues at ~TS18 (Fig. 5I) . In all tissues, all known Dlk1 isoforms were amplified, with the Dlk1-A and Dlk1-C/C2 isoforms exhibiting the highest levels of expression. As observed previously, Dlk1-D/D2 is expressed at very low levels in all tissues examined. These data indicate that all Dlk1 isoforms are expressed in a variety of tissues at this early stage of development.
Discussion
The expression patterns described here suggest that Dlk1 may have specific functions during early stages of mouse development. Dlk1 has a well-documented role in mesenchymal cell fate, and Dlk1 function in the PSM may be related to a role in maintaining mesenchymal cells in an immature state prior to differentiation (Sul, 2009; Wang and Sul, 2009 ). The observed expression in the somites and limb buds could reflect the suggested role for Dlk1 in regulating embryonic muscle development (Andersen et al., 2013; Waddell et al., 2010) . Dlk1 has previously been shown to be expressed in hepatoblasts and hepatic stellate precursor cells, thus the observed liver expression is likely indicative of these cell populations (Zhu et al., 2012) .
We are the first to report strong expression of Dlk1 in the branchial arches and their derivatives and in the olfactory epithelium. The early and robust expression in the branchial arch mesenchyme may reflect functional roles for Dlk1 during craniofacial development, while expression of Dlk1 at the periphery of the invaginating nasal pit, the domain of olfactory epithelial morphogenesis where olfactory neural stem and progenitor cells reside, is consistent with the described role of Dlk1 in neural stem cell maintenance (Ferrón et al., 2011; Kawauchi et al., 2005; Schmidt et al., 2000) . In support of this, asymmetric expression of Dlk1 at the peripheral OE is reminiscent of Sox2 expression in this tissue (Chen et al., 2009) . A recent study used section IHC to detect DLK1 protein expression at similar stages to those reported here (Falix et al., 2013) , and identified protein expression in many of the same structures during early embryogenesis. These results are complementary, as together these studies allow us to assess both protein and RNA expression in embryonic sections as well as in whole mounts. The data reported here identify additional sites of expression, and shed light on the control of transcript splicing, which is not possible using antibody analysis. Together, these findings allow us to assess the effects of transcriptional, post transcriptional and post-translational control of Dlk1 in the early embryo.
Our RT-PCR results demonstrate that Dlk1 splice variants encoding both membrane bound and secreted versions of the DLK1 protein are co-expressed in an array of developmentally distinct tissues. The fact that in all tissues examined Dlk1-A (secreted) and Dlk1-C/C2 (membrane bound) are expressed at the highest levels, indicates that both forms of the protein are functional during early embryonic development. Further examination will be needed to determine whether individual cells within the developing tissues may express specific Dlk1 isoforms.
In summary, we have demonstrated for the first time that all known Dlk1 isoforms are expressed during early embryogenesis. We find that Dlk1 expression patterns can be correlated with previous in vitro and tissue-specific functional studies, and expression studies at later developmental stages. We have also described for the first time expression of Dlk1 in the branchial arches and the olfactory epithelium. Finally, we have found that soluble and membrane-bound Dlk1 isoforms are broadly co-expressed during early embryonic development, with both membrane bound and secreted isoforms being found in similar embryonic tissues. In light of previous work studying the functions of the DLK1 splice variants (Garcés et al., 1999) , this suggests that both DLK1 variants have roles in organogenesis.
Materials and Methods
Timed pregnancy and embryo collection
Embryos were collected from timed pregnancies of FVB/NJ mice, with noon the day of plug identification designated as 0.5 d.p.c. Embryos were further staged according to Theiler. On this background, TS12 was ~ 8.0 d.p.c., TS14 was ~ 8.5 d.p.c., TS16 was ~ 9.5 d.p.c., TS18 was ~ 10.5 d.p.c., and TS20 was ~11.5 d.p.c. All mice were maintained under the care of the Ohio State University IACUC.
In situ hybridization
RNA is situ hybridization using digoxygenin-labeled probes was performed using standard protocols (Shifley and Cole, 2008) . For simultaneous detection of all Dlk1 transcripts (pan-Dlk1 expression), a 382 bp fragment of the cDNA, was amplified by RT-PCR using primers SC-628 (5'-tgtcaatggagtctgcaagg-3') and SC-629: (5'-atcgttctcgcatgggttag-3'). For specific detection of Dlk1-A, a 185 bp fragment, corresponding to the intron of the Dlk1-B isoform was amplified by RT-PCR using the primers: SC-690 (5'-tgagcttcgagtgtctgtgc-3') and SC-691 (5'-tttcatggacaccttcagga-3').
RT-PCR
Total poly(A) + -selected RNA was extracted from dissected embryos and first strand cDNA synthesis was completed (SuperScript III, Invitrogen). All Dlk1 transcripts were amplified simultaneously using the primers SC-655 (5'-cacctgggttctctggaaag-3') and SC-656 (5'-acgcccaggatggtgaag-3'), which yields predicted bands corresponding to Dlk1-A at 595 bp, Dlk1-B at 442 bp, Dlk1-C/C2 at 376 bp, and Dlk1-D/D2 at 310 bp.
